# Levemir

NDC: 50090-1276
Generic name: insulin detemir
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20060327

FDA application: BLA021536

## Active ingredients

- INSULIN DETEMIR: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-1276"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-1276
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82192527-99aa-4b53-8ce9-9173668d309c